Regional anthropometry changes in antiretroviral-naïve persons initiating a zidovudine-containing regimen in Mbarara, Uganda

AIDS Research and Human Retroviruses

Volumn 27, Issue 7, 2011, Pages 785-791

  Thompson, Vanessa ^a   Medard, Bitekyerezo ^b   Taseera, Kabanda ^b   Chakera, Ali J ^c   Andia, Irene ^b   Emenyonu, Nneka ^d   Hunt, Peter W ^a   Martin, Jeffrey ^e   Scherzer, Rebecca ^a,f   Weiser, Sheri D ^a   Bangsberg, David R ^d,g,h,i   Tien, Phyllis C ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g HARVARD UNIVERSITY   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Harvard Initiative for Global Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ABDOMEN; ADULT; ANALYTIC METHOD; ANTHROPOMETRY; ANTIVIRAL THERAPY; ARM; ARTICLE; BIOELECTRIC IMPEDANCE ANALYSIS; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; FEMALE; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; THIGH; UGANDA; WAIST CIRCUMFERENCE;

ADULT; ANTI-HIV AGENTS; BODY COMPOSITION; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LONGITUDINAL STUDIES; MALE; UGANDA;

EID: 79959835844     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0272     Document Type: Article

References (27)

1. Bussmann H, Wester CW, Thomas A, et al.: Response to zidovudine/ didanosine-containing combination anti-retroviral therapy among HIV-1 subtype C-infected adults in Botswana: Two-year outcomes from a randomized clinical trial. J Acquir Immune Defic Syndr 2009;51(1):37-46.
2. Mutimura E, Stewart A, Rheeder P, and Crowther NJ: Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007;46(4):451-455. (Pubitemid 350098696)
3. van Griensven J, De Naeyer L, Mushi T, et al.: High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc Trop Med Hyg 2007;101(8):793-798. (Pubitemid 46947861)
4. Mercier S, Gueye NF, Cournil A, et al.: Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4-to 9-year antiretroviral therapy in Senegal: A case-control study. J Acquir Immune Defic Syndr 2009;51(2):224-230.
5. Mallal SA, John M, Moore CB, James IR, and McKinnon EJ: Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000;14(10):1309-1316. (Pubitemid 30459502)
6. Mallon PW, Miller J, Cooper DA, and Carr A: Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 2003;17(7):971-979. (Pubitemid 36549708)
7. Mulligan K, Parker RA, Komarow L, et al.: Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. J Acquir Immune Defic Syndr 2006;41(5):590-597.
8. Shlay JC, Sharma S, Peng G, Gibert CL, and Grunfeld C: Long-term subcutaneous tissue changes among anti-retroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine. J Acquir Immune Defic Syndr 2008;48(1):53-62. (Pubitemid 351600854)
9. FRAM Study Investigators: Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005;40(2): 121-131.
10. FRAM Study Investigators: Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr Hum Retro-virol 2006;42(5):562-571.
11. Mutimura E, Stewart A, and Crowther NJ: Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda. AIDS Res Ther 2007;4:19.
12. Ammassari A, Murri R, Pezzotti P, et al.: Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001;28(5):445-449. (Pubitemid 34033195)
13. Duran S, Saves M, Spire B, et al.: Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS 2001;15(18):2441-2444. (Pubitemid 34014613)
14. George JA, Venter WD, Van Deventer HE, and Crowther NJ: A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Res Hum Retroviruses 2009;25(8):771-781.
15. Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, and Grunfeld C: The study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design, and sample characteristics. Am J Epidemiol 2006;163(9):860-869.
16. Kotler DP, Burastero S, Wang J, and Pierson RN, Jr: Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: Effects of race, sex, and disease. Am J Clin Nutr 1996;64(3 Suppl):489S-497S. (Pubitemid 26320118)
17. Laird NM and Ware JH: Random-effects models for longitudinal data. Biometrics 1982;38(4):963-974.
18. Hernan MA, Brumback B, and Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000;11(5): 561-570. (Pubitemid 30660035)
19. Matsuyama Y: Sensitivity analysis for the estimation of rates of change with non-ignorable drop-out: An application to a randomized clinical trial of the vitamin D3. Statist Med 2003; 22(5):811-827. (Pubitemid 36266968)
20. Robins JM and Finkelstein DM: Correcting for noncompli-ance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000;56(3):779-788.
21. Shafer JL: Multiple Imputation: A primer. Stat Methods Med Res 1999;8:3-15.
22. Grinspoon S, Thomas L, Miller K, Pitts S, Herzog D, and Klibanski A: Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr 2001;73(5):865-869. (Pubitemid 32405981)
23. Iketani T, Kiriike N, Nagata T, and Yamagami S: Altered body fat distribution after recovery of weight in patients with anorexia nervosa. Int J Eat Disord 1999;26(3):275-282. (Pubitemid 29411694)
24. Mayer L, Walsh BT, Pierson RN, Jr, et al.: Body fat redistribution after weight gain in women with anorexia nervosa. Am J Clin Nutr 2005;81(6):1286-1291. (Pubitemid 41710228)
25. de Alvaro MT, Munoz-Calvo MT, Barrios V, et al.: Regional fat distribution in adolescents with anorexia nervosa: Effect of duration of malnutrition and weight recovery. Eur J En-docrinol 2007;157(4):473-479. (Pubitemid 350018451)
26. Coroas A, Oliveira JG, Sampaio S, et al.: Nutritional status and body composition evolution in early post-renal transplantation: Is there a female advantage? Transplant Proc 2005;37(6):2765-2770. (Pubitemid 41354730)
27. Kotler DP, Rosenbaum K, Wang J, and Pierson RN: Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20(3):228-237. (Pubitemid 29156959)